{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:14:06Z","timestamp":1757704446097,"version":"3.37.3"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T00:00:00Z","timestamp":1562803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"B\u00f8rnecancerfonden (DK)"},{"DOI":"10.13039\/100008368","name":"Gigtforeningen","doi-asserted-by":"publisher","award":["R128-A2294; R141-A4002"],"award-info":[{"award-number":["R128-A2294; R141-A4002"]}],"id":[{"id":"10.13039\/100008368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007460","name":"Arvid Nilssons Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007460","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0219539","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T17:35:22Z","timestamp":1562866522000},"page":"e0219539","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Increased methotrexate intolerance in juvenile idiopathic arthritis compared to acute lymphoblastic leukaemia in children"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9490-1333","authenticated-orcid":true,"given":"Nini","family":"Kyvsgaard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torben Stamm","family":"Mikkelsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikael","family":"Thastum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Estmann","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peder Skov","family":"Wehner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karsten","family":"Nysom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Troels","family":"Herlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,7,11]]},"reference":[{"issue":"16","key":"ref1","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJM199204163261602","article-title":"Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group","volume":"326","author":"EH Giannini","year":"1992","journal-title":"N Engl J Med"},{"issue":"13","key":"ref2","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1001\/jama.294.13.1671","article-title":"Medical treatment of juvenile idiopathic arthritis","volume":"294","author":"PJ Hashkes","year":"2005","journal-title":"JAMA"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.20460","article-title":"2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features","volume":"63","author":"T Beukelman","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/ejh.12097","article-title":"Risk group assignment differs for children and adults 1\u201345 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol","volume":"90","author":"N Toft","year":"2013","journal-title":"Eur J Haematol"},{"issue":"3","key":"ref5","first-page":"480","article-title":"Psychological side effects of MTX treatment in juvenile idiopathic arthritis: a pilot study","volume":"25","author":"A van der Meer","year":"2007","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"ref6","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/art.30367","article-title":"High prevalence of methotrexate intolerance in juvenile idiopathic arthritis: development and validation of a methotrexate intolerance severity score","volume":"63","author":"M Bulatovic","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"6","key":"ref7","first-page":"901","article-title":"Countermeasures against methotrexate intolerance in juvenile idiopathic arthritis instituted by parents show no effect","volume":"56","author":"A Scheuern","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00280-014-2613-7","article-title":"Myelotoxicity after high-dose methotrexate in childhood acute leukemia is influenced by 6-mercaptopurine dosing but not by intermediate thiopurine methyltransferase activity","volume":"75","author":"M Levinsen","year":"2015","journal-title":"Cancer Chemother Pharmacol"},{"issue":"10","key":"ref9","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2217\/pgs.14.106","article-title":"Pharmacogenetics of childhood acute lymphoblastic leukemia","volume":"15","author":"E Lopez-Lopez","year":"2014","journal-title":"Pharmacogenomics"},{"key":"ref10","first-page":"118","article-title":"Childhood and adolescent lymphoid and myeloid leukemia","author":"CH Pui","year":"2004","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/01.rhu.0000173616.81928.44","article-title":"Gastrointestinal symptoms and their association with health-related quality of life of children with juvenile rheumatoid arthritis: validation of a gastrointestinal symptom questionnaire","volume":"11","author":"HI Brunner","year":"2005","journal-title":"J Clin Rheumatol"},{"issue":"2","key":"ref12","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"RE Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"ref13","article-title":"Results of NOPHO ALL2008 treatment for patients aged 1\u201345 years with acute lymphoblastic leukemia","author":"N Toft","year":"2017","journal-title":"Leukemia"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"PA Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s10067-017-3638-1","article-title":"MISS questionnaire in French version: a good tool for children and parents to assess methotrexate intolerance","volume":"36","author":"A Chausset","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","DOI":"10.1186\/s12969-016-0099-z","article-title":"Methotrexate efficacy, but not its intolerance, is associated with the dose and route of administration","volume":"14","author":"J Franova","year":"2016","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","DOI":"10.1186\/s12969-016-0071-y","article-title":"Mutations in the MTHFR gene are not associated with Methotrexate intolerance in patients with juvenile idiopathic arthritis","volume":"14","author":"A Scheuern","year":"2016","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref18","doi-asserted-by":"crossref","DOI":"10.1186\/s12969-015-0002-3","article-title":"Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study","volume":"13","author":"EH van Dijkhuizen","year":"2015","journal-title":"Pediatr Rheumatol Online J"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10067-013-2389-x","article-title":"Methotrexate-induced nausea and vomiting in adolescent and young adult patients","volume":"33","author":"P Patil","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5114\/reum.2016.58757","article-title":"Methotrexate efficacy and tolerability after switching from oral to subcutaneous route of administration in juvenile idiopathic arthritis","volume":"54","author":"Z Zuber","year":"2016","journal-title":"Reumatologia"},{"issue":"1","key":"ref21","first-page":"179","article-title":"The role of subcutaneous administration of methotrexate in children with juvenile idiopathic arthritis who have failed oral methotrexate","volume":"31","author":"K Alsufyani","year":"2004","journal-title":"J Rheumatol"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00520-016-3330-z","article-title":"2016 updated MASCC\/ESMO consensus recommendations: Anticipatory nausea and vomiting in children and adults receiving chemotherapy","volume":"25","author":"LL Dupuis","year":"2017","journal-title":"Support Care Cancer"},{"issue":"10","key":"ref23","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s00520-010-0980-0","article-title":"Anticipatory nausea and vomiting","volume":"19","author":"JA Roscoe","year":"2011","journal-title":"Support Care Cancer"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/MIB.0000000000001014","article-title":"Prevalence and Risk Factors for Symptoms of Methotrexate Intolerance in Pediatric Inflammatory Bowel Disease","volume":"23","author":"C Dupont-Lucas","year":"2017","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"ref25","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/pbc.25063","article-title":"Guideline for the prevention and treatment of anticipatory nausea and vomiting due to chemotherapy in pediatric cancer patients","volume":"61","author":"LL Dupuis","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","DOI":"10.1186\/s12969-018-0228-y","article-title":"Successful treatment of methotrexate intolerance in juvenile idiopathic arthritis using eye movement desensitization and reprocessing\u2014treatment protocol and preliminary results","volume":"16","author":"L Hofel","year":"2018","journal-title":"Pediatr Rheumatol Online J"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0219539","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T20:00:33Z","timestamp":1588968033000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0219539"}},"subtitle":[],"editor":[{"given":"Yan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,7,11]]},"references-count":26,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,7,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0219539","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2019,7,11]]}}}